• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by Sabra Health Care REIT Inc.

    5/15/25 4:10:13 PM ET
    $SBRA
    Real Estate Investment Trusts
    Real Estate
    Get the next $SBRA alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001145246
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    Sabra Health Care REIT, Inc.
    SEC File Number
    001-34950
    Address of Issuer
    1781 Flight Way
    Tustin
    CALIFORNIA
    92782
    Phone
    888-393-8248
    Name of Person for Whose Account the Securities are To Be Sold
    Michael J. Foster
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Director

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common Stock
    Equiniti Trust Company, LLC
    48 Wall St., Floor 23
    New York � NY � 10005
    1100019250023793646005/15/2025
    Nasdaq


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common Stock12/17/2010From issuer in connection with annual awards for service on the Board (vested and paid out)Sabra Health Care REIT, Inc.Checkbox not checked4618012/17/2010Board Service from Incentive Plan

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Nothing to ReportCheckbox checked

    144: Remarks and Signature

    Remarks
    Prior to the proposed sale, 22,442 shares of Common Stock are held directly by Mr. Foster, which are not subject to any vesting or deferral requirements. The referenced securities to be sold were acquired from 12/17/2010 to 2/28/2025 in connection with Mr. Foster's service on the Board of issuer.
    Date of Notice
    05/15/2025

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    /s/ Michael L. Costa, as Attorney-in-Fact

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $SBRA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SBRA

    DatePrice TargetRatingAnalyst
    1/17/2025Buy → Hold
    Truist
    1/7/2025$20.00Mkt Perform → Mkt Outperform
    JMP Securities
    12/5/2024$20.00Outperform → Neutral
    Mizuho
    10/1/2024$16.00 → $20.00Equal Weight → Overweight
    Wells Fargo
    9/13/2024$17.00 → $20.00Neutral → Buy
    Citigroup
    1/30/2024$21.00Buy
    Deutsche Bank
    10/17/2023$16.00Outperform → Market Perform
    BMO Capital Markets
    10/16/2023$13.00 → $15.00Underweight → Equal Weight
    Wells Fargo
    More analyst ratings

    $SBRA
    SEC Filings

    See more
    • SEC Form 144 filed by Sabra Health Care REIT Inc.

      144 - Sabra Health Care REIT, Inc. (0001492298) (Subject)

      5/15/25 4:10:13 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • SEC Form 10-Q filed by Sabra Health Care REIT Inc.

      10-Q - Sabra Health Care REIT, Inc. (0001492298) (Filer)

      5/5/25 4:06:34 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Sabra Health Care REIT, Inc. (0001492298) (Filer)

      5/5/25 4:05:31 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Cusack Catherine bought $40,315 worth of shares (2,500 units at $16.13), increasing direct ownership by 4% to 60,583 units (SEC Form 4)

      4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

      2/25/25 5:04:04 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Cusack Catherine bought $101,010 worth of shares (7,000 units at $14.43), increasing direct ownership by 18% to 46,385 units (SEC Form 4)

      4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

      5/23/24 7:00:45 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Financials

    Live finance-specific insights

    See more
    • Sabra Reports First Quarter 2025 Results; Reiterates 2025 Guidance

      Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the first quarter of 2025. FIRST QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the first quarter of 2025 were as follows: Net Income: $0.17 FFO: $0.36 Normalized FFO: $0.35 AFFO: $0.37 Normalized AFFO: $0.37 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.19x Senior Housing - Leased: 1.41x Behavioral Health, Specialty Hospitals and Other: 3.77x Same store managed senior housing Cash NOI increased 16.9% on a year-over-year basis. During the first quarter of 2025, Sabra exercised its option to ac

      5/5/25 4:05:00 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call

      Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2025 first quarter earnings release on May 5, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 first quarter results will be held on Tuesday, May 6th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/667976677. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, op

      4/21/25 4:05:00 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Reports Fourth Quarter 2024 Results; Introduces 2025 Guidance

      Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the fourth quarter of 2024. FOURTH QUARTER 2024 RESULTS AND RECENT EVENTS Results per diluted common share for the fourth quarter of 2024 were as follows: Net Income: $0.19 FFO: $0.36 Normalized FFO: $0.35 AFFO: $0.36 Normalized AFFO: $0.36 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.09x Senior Housing - Leased: 1.36x Behavioral Health, Specialty Hospitals and Other: 3.66x Same store managed senior housing Cash NOI increased 17.9% on a year-over-year basis. As previously announced, in the fourth quarter of 2024, Sabra cl

      2/19/25 4:05:00 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Sabra Health Care REIT downgraded by Truist

      Truist downgraded Sabra Health Care REIT from Buy to Hold

      1/17/25 11:05:39 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT upgraded by JMP Securities with a new price target

      JMP Securities upgraded Sabra Health Care REIT from Mkt Perform to Mkt Outperform and set a new price target of $20.00

      1/7/25 8:27:55 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT downgraded by Mizuho with a new price target

      Mizuho downgraded Sabra Health Care REIT from Outperform to Neutral and set a new price target of $20.00

      12/5/24 8:19:25 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Sabra Health Care REIT Inc.

      SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)

      10/18/24 11:35:05 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • SEC Form SC 13G/A filed by Sabra Health Care REIT Inc. (Amendment)

      SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)

      2/13/24 5:13:53 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • SEC Form SC 13G/A filed by Sabra Health Care REIT Inc. (Amendment)

      SC 13G/A - Sabra Health Care REIT, Inc. (0001492298) (Subject)

      2/13/24 2:19:42 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Sabra Health Care REIT, Inc. to Participate in Nareit's REITweek 2025 Investor Conference and Attend ASHA's 2025 Mid-Year Meeting

      Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Talya Nevo-Hacohen, the company's Chief Investment Officer, Darrin Smith, the company's Executive Vice President of Investments, and Lukas Hartwich, the company's Executive Vice President of Finance, will participate in Nareit's REITweek 2025 Investor Conference June 2 – 5, 2025 at the New York Hilton Midtown in New York, New York. Additionally, Talya Nevo-Hacohen, Darrin Smith, and other members of the company, will attend ASHA's 2025 Mid-Year Meeting on June 9 – 10, 2025, at the Omni Interlocken Hotel, in Broom

      5/22/25 4:05:00 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Reports First Quarter 2025 Results; Reiterates 2025 Guidance

      Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA) today announced its results of operations for the first quarter of 2025. FIRST QUARTER 2025 RESULTS AND RECENT EVENTS Results per diluted common share for the first quarter of 2025 were as follows: Net Income: $0.17 FFO: $0.36 Normalized FFO: $0.35 AFFO: $0.37 Normalized AFFO: $0.37 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.19x Senior Housing - Leased: 1.41x Behavioral Health, Specialty Hospitals and Other: 3.77x Same store managed senior housing Cash NOI increased 16.9% on a year-over-year basis. During the first quarter of 2025, Sabra exercised its option to ac

      5/5/25 4:05:00 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call

      Sabra Health Care REIT, Inc. (NASDAQ:SBRA) announced today that it will issue its 2025 first quarter earnings release on May 5, 2025, after the close of trading. A conference call with a simultaneous webcast to discuss the 2025 first quarter results will be held on Tuesday, May 6th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID number is 1382596. The webcast URL is https://events.q4inc.com/attendee/667976677. A digital replay of the call will be available on our website at www.sabrahealth.com. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, op

      4/21/25 4:05:00 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate

    $SBRA
    Leadership Updates

    Live Leadership Updates

    See more

    $SBRA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Sabra Health Care REIT Appoints Jessica Flores as Chief Accounting Officer

      Sabra Health Care REIT, Inc. ("Sabra") (NASDAQ:SBRA) today announced that Jessica Flores has been appointed Executive Vice President and Chief Accounting Officer and, in such capacity, has been designated by the Company's Board of Directors as the Company's principal accounting officer. Ms. Flores currently serves as Sabra's Senior Vice President – Finance and Controller, a position she has held since January 2022. Ms. Flores joined Sabra in March 2011 and held various leadership positions overseeing Sabra's accounting during that time. Ms. Flores has over 15 years of experience in accounting, finance and real estate investments, having previously worked for KBS Realty Advisors and Deloit

      1/4/24 9:15:00 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT Appoints Katie Cusack to its Board of Directors

      IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced the appointment of Katie Cusack to its Board of Directors. Ms. Cusack currently serves as Chief Operating Officer of Cornell Capital LLC, a $4 billion private investment firm with offices in New York and Hong Kong. From 2007 to 2020, Ms. Cusack served in various capacities at Credit Suisse, including Chief Operating Officer for the Investment Banking Division in both Asia Pacific and Europe, Middle East and Africa, and as the Head of Ultra-High Net Worth Coverage. Prior to joining Credit Suisse, Ms. Cusack served as a Managing Director at MTS Health Partners LP, where she provided

      1/12/21 9:05:00 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Sabra Health Care REIT Appoints Ann Kono to Board of Directors

      IRVINE, Calif.--(BUSINESS WIRE)--Sabra Health Care REIT, Inc. (“Sabra”) (Nasdaq: SBRA) today announced the appointment of Ann Kono to its Board of Directors. Ms. Kono currently serves as the chief executive officer of Leda Advisory Group, a management consulting firm she founded in January 2019 that partners with startup companies to advise on growth and scale. Prior to founding Leda, Ms. Kono spent 11 years at Ares Management Corporation, where she held the position of Chief Information and Risk Officer, and oversaw Operational, Investment and Enterprise Risks. Ms. Kono also serves on the board of directors of Stable Road Acquisition Company, a position she has held since 2019. M

      12/21/20 9:00:00 AM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Director Foster Michael J sold $200,376 worth of shares (11,000 units at $18.22), decreasing direct ownership by 15% to 64,725 units (SEC Form 4)

      4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

      5/22/25 2:55:39 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Director Porter Clifton J Ii was granted 855 shares, increasing direct ownership by 2% to 48,721 units (SEC Form 4)

      4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

      3/4/25 2:49:21 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate
    • Director Malehorn Jeffrey A. was granted 946 shares, increasing direct ownership by 1.00% to 95,725 units (SEC Form 4)

      4 - Sabra Health Care REIT, Inc. (0001492298) (Issuer)

      3/4/25 2:48:55 PM ET
      $SBRA
      Real Estate Investment Trusts
      Real Estate